The rise in the occurrence of chronic illnesses such as diabetes and cancer throughout the world is driving expansion of the global anti-biofilm wound dressing market. Non-communicable illnesses are becoming more prevalent due to various factors such as smoking, alcohol usage, antibiotic resistance, and unhealthy and sedentary lifestyles.
Healthcare facilities, such as hospitals, have been overburdened as a result of the COVID-19 pandemic, with many Covid positive individuals; as a result, several nations have postponed elective surgeries as well as other healthcare operations indefinitely. Patients with acute and persistent wounds must thus be treated either at outpatient clinics or at home. As a result, demand for wound care products at home, like anti-biofilm wound dressing, has risen. In addition to that, as the elderly population is at a higher risk of infection and is unable to attend a healthcare facility, the need for home healthcare is growing. Furthermore, many people have turned to online therapy for help with their health problems. These factors are likely to drive growth of the global anti-biofilm wound dressing market in the near future.
This study from Transparency Market Research (TMR) provides a complete insight of the global anti-biofilm wound dressing market. It provides well-researched data on a variety of market aspects in order to provide useful business input for profit generation.
ConvaTec Group Plc (Conva Tec) declared the official launch of an innovative product called "ConvaMax" in January 2020. Diabetic foot ulcers, pressure ulcers, leg ulcers, and dehisced surgical wounds are all treated with this new medication. Additionally, the product is available in non-adhesive forms as well, allowing total freedom in integrating compression bands or an extra main dressing to support care regimen.
The noted players that are operational in the global anti-biofilm wound dressing market are Coloplast A/S, Smith & Nephew PLC., ConvaTec Group plc., The 3M Company, Mölnlycke Health Care AB, and Urgo Medical.
Below-mentioned market trends and opportunities mark the global anti-biofilm wound dressing market:
Diabetic foot ulcers affect around 2% to 10% of diabetics, according to studies done by B. Braun Melsungen AG in 2018. Furthermore, according to the American College of Physicians, the number of new cases every year for diabetic foot ulcers is about 6.3 % in 2017, and the incidence rate of foot ulcers in diabetic individuals in their lifetime ranges from 19% to 34%. Because anti-biofilm wound dressing solutions are highly suggested for treating chronic wounds, market growth is expected to observe high growth rate..
The majority of surgical wounds following cancer surgery are big and deep, generating exudates that must be managed on a daily basis. Anti-biofilm wound dressings, such as iodine and silver-based wound dressings, aid in wound management and infection prevention. As a result, the growing prevalence of chronic illnesses is projected to enhance product demand, thereby pushing global anti-biofilm wound dressing market.
The market is expected to be driven by an increase in the number of road accidents, trauma events, and burns throughout the world. According to the World Health Organization (WHO), around 1,000,000 individuals in India suffering from serious or moderate burns each year.
North America dominated the market with a substantial share of the global anti-biofilm wound dressing market and is expected to dominate the market in the near future. Some of the reasons predicted to drive the market include existence of many major competitors in the area, an increase in the number of sports injuries, and a rise in the number of traffic accidents. Furthermore, the existence of a well-developed healthcare infrastructure as well as advantageous reimbursement policies is projected to drive market expansion during the forecast period.
Asia Pacific is expected to expand at the rapid growth rate during the forecast period. The presence of emerging nations such as China, India, and Japan in the Asia Pacific region is expected to boost market expansion.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.